← Back
$HALO All transactions

HALOZYME THERAPEUTICS, INC.

A

$ Value

$0

Shares

165,522

Price

$0

Filed

Dec 11

Insider

Name

Torley Helen

Title

PRESIDENT AND CEO

CIK

0001528185

Roles

Director Officer

Transaction Details

Transaction Date

2025-12-09

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

165,522

Footnotes

Represents the grant of performance-based vesting Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of HALO common stock. The target number of Restricted Stock Units subject to the award is indicated. Up to two hundred percent (200%) of the target Restricted Stock Units could vest if the average closing price of HALO common stock over a period of 20 consecutive trading days during a four-year performance period following the grant of the award equals or exceeds certain price levels specified in the award (with 50% of target number of units vesting at $115 and an additional 50% of the target number of units vesting at each of $130, $145 and $170) and, in each case, only if the Reporting Person remains employed with the Registrant through the end of the performance period (subject to certain exceptions provided in the applicable award agreement).

Filing Info

Accession No.

0001159036-25-000073

Form Type

4

Issuer CIK

0001159036

Torley Helen's History

Date Ticker Type Value
2026-04-06 HALO M $121K
2026-04-06 HALO $373K
2026-04-06 HALO $262K
2026-04-06 HALO M $121K
2026-04-02 HALO M $241K
2026-04-02 HALO $1.0M
2026-04-02 HALO $273K
2026-04-02 HALO M $241K
2026-04-01 HALO M $241K
2026-04-01 HALO $1.2M

Other Insiders at HALO (90d)

Insider Bought Sold Last
RAMSAY DAVID A
Interim CFO
2026-04-01
Torley Helen
PRESIDENT AND CEO
$3.2M 2026-04-06